Details of the Drug

General Information of Drug (ID: DM0IRFU)

Drug Name
MK-8237
Indication
Disease Entry ICD 11 Status REF
Allergic asthma CA23.0 Phase 3 [1]
Cross-matching ID
TTD ID
D0G3OI

References

1 ClinicalTrials.gov (NCT01700192) Long-Term Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607). U.S. National Institutes of Health.